Disclosure: This is an affiliate site. We may earn compensation from partners. Full disclosure | Medical disclaimer
By Lemme (Kourtney Kardashian Barker)
Not publicly confirmed
Capsule
30
August 31, 2026
Lemme GLP-1 Daily is a dietary supplement. It is not FDA-approved, has not been reviewed for safety or effectiveness before sale, and is not a treatment for any disease. It is not equivalent to and does not replace prescription semaglutide or tirzepatide. No claim on this page should be read as a promise of weight loss.
Lemme GLP-1 Daily is the highest-profile product in this category, from the celebrity supplement brand Lemme. It markets itself as the first GLP-1 supplement built on three clinically studied, patented ingredients.
Those three are Superesa saffron extract, Morosil red orange fruit extract and Eriomin lemon bioflavonoid complex. Lemme states the Eriomin complex is shown in human clinical studies to promote increased GLP-1 levels and support metabolic health.
This product is the clearest illustration in the category of the "clinically studied ingredients" pattern. The studies belong to the patented ingredient suppliers and were run on those extracts individually. Independent reviewers examining the product concluded that despite the GLP-1 branding, none of the core ingredients have strong evidence for actual GLP-1 pathway activation.
Serving size: Per label · 30 servings per container
| Ingredient | Amount | % DV |
|---|---|---|
| Superesa saffron extractA patented saffron extract with supplier-sponsored human studies, marketed for appetite and snacking behaviour. | Amount not publicly confirmed | Daily Value not established |
| Morosil red orange fruit extractA patented Moro blood orange extract marketed for body composition support. | Amount not publicly confirmed | Daily Value not established |
| Eriomin lemon bioflavonoid complexA patented citrus flavonoid complex which Lemme states is shown in human clinical studies to promote increased GLP-1 levels. | Amount not publicly confirmed | Daily Value not established |
Not publicly confirmed in the sources available at review. Check the current label.
Marketed to support healthy weight management, reduce appetite and boost GLP-1.
Lemme positions the three patented ingredients as clinically studied for weight management, appetite reduction and GLP-1 support, with the Eriomin complex specifically credited for increased GLP-1 levels.
Each of the three ingredients is a patented extract with associated human studies, which is more than many supplement ingredients have. Eriomin in particular has published human work relating to GLP-1 levels.
Independent reviewers examining the product concluded that despite the GLP-1 branding, none of the core ingredients have strong evidence for actual GLP-1 pathway activation. Medical reviewers have described likely small effects on snacking and blood sugar without reliable weight-loss effects.
NBC News reporting notes that ingredients appearing on GLP-1 supplement labels — including saffron extract — have a minimal body of supporting evidence.
No published, peer-reviewed clinical trial has tested this finished combination at these doses for weight loss. The supporting studies belong to the individual ingredient suppliers, were run separately, and in several cases were funded by those suppliers. Ingredient amounts are not publicly confirmable, so you cannot check whether the doses match the studied doses — which is the single most important thing to know about a product sold on "clinically studied ingredients."
Per the current product label.
Standard supplement cautions. Consult a physician before use if pregnant, nursing, taking medication or managing a medical condition. Saffron extracts can interact with some medications — check with a pharmacist.
Contains citrus-derived ingredients. Check the current label for a full allergen statement.
We could not confirm current pricing from the sources available at review. Check lemmelive.com directly.
Lemme offers subscription purchasing on its own site. Confirm current terms at checkout.
Not publicly confirmed in the material we reviewed.
Direct from Lemme and through Amazon. No cold chain required.
Pricing reflects what Lemme (Kourtney Kardashian Barker) and named third-party retailers published as of August 31, 2026. Supplement pricing changes frequently — confirm at checkout.
People who specifically want these three patented extracts in one capsule and are comfortable with modest, uncertain effects. We would not recommend it on the strength of its GLP-1 branding.
You are expecting anything approaching prescription GLP-1 results, you want published per-ingredient dosing you can check against research, or you take medications that may interact with saffron extract without checking first.
Three patented extracts: Superesa saffron extract, Morosil red orange fruit extract and Eriomin lemon bioflavonoid complex. Individual amounts are not publicly confirmable from the sources available at review, which limits how far the "clinically studied" claim can be checked.
Independent reviewers examining the product concluded that despite the GLP-1 branding, none of the core ingredients have strong evidence for actual GLP-1 pathway activation, and medical reviewers have described likely small effects on snacking and blood sugar without reliable weight-loss effects. No published trial has tested this finished combination for weight loss.
It means the individual ingredients have studies attached to them — usually run by the patent holder, at particular doses, in particular populations. It does not mean this product was tested. Since Lemme does not publicly confirm its per-ingredient amounts, you cannot verify whether the doses here match the doses studied.
No. Prescription GLP-1 medications produce roughly 15% to 21% of body weight loss in clinical trials. Reported weight loss across over-the-counter GLP-1 supplements generally is roughly 1 to 4 pounds at best. Dietary supplements are not FDA-approved.
We could not confirm current pricing from the sources available at the time of review. Check lemmelive.com or Amazon directly for the current price and subscription terms.
Every ingredient, dose, price and policy on this page traces to one of these, checked August 31, 2026.
Speak to a qualified healthcare provider or pharmacist before starting this or any supplement — particularly if you take prescription medication, are pregnant or breastfeeding, are immunocompromised, have a chronic condition, or are already taking a GLP-1. A pharmacist can screen your full medication list for interactions in a few minutes, and that is worth doing before you spend anything.
Explore more expert guides and reviews to help you on your weight loss journey
Complete Zepbound dosage chart with escalation schedule, maintenance doses, and weight loss results by dose.
Compared on protein per serving and real cost: Clean Eatz from $8.99, Factor $11-$14, bistroMD $8-$13.
Compare top GLP-1 medication providers with expert reviews, pricing, and user ratings.
Complete nutrition guide for GLP-1 users: what to eat, meal planning, and dietary strategies.
Complete cost comparison: tirzepatide vs semaglutide including brand-name, compounded, and insurance coverage.
Cardiovascular risk, chronic kidney disease and sleep apnea: the approved non-weight-loss indications.
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not FDA-approved, are not reviewed for safety or effectiveness before sale, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page is a substitute for prescription medication, and no supplement described here has been shown to produce weight loss comparable to a prescription GLP-1 medication. Individual results vary. Supplements can interact with prescription medications — talk to a qualified healthcare provider or pharmacist before starting anything, particularly if you are pregnant, breastfeeding, immunocompromised, taking other medication, or already on a GLP-1.
This page contains affiliate links, and we may earn compensation if you use them. Last reviewed: August 30, 2026